MorphoSys' Q2 Revenue Grows 42 Percent Though Profit Turns to Loss | GenomeWeb
NEW YORK (GenomeWeb News) – MorphoSys today reported a net loss for the second quarter although revenue grew 47 percent.
 
Receipts for the three months ended June 30 increased to $11.7 million from $7.9 million year over year.
 
R&D costs increased 24 percent to $4 million from $3 million from the comparable quarter a year ago.
 
MorphoSys reported a net loss of 400,000 for the quarter, compared to a net profit of $1.3 million during the comparable period last year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.